Conditional biologics in cancer immunotherapy: mechanisms, applications and clinical progress.

Keenan BP, Killebrew JR, Hollenbaugh D, Fong L

DOI: 10.1038/s41573-026-01552-x
Published: 2026 Nov 9
Container: Nature reviews. Drug discovery
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41573-026-01552-x,
  title = {Conditional biologics in cancer immunotherapy: mechanisms, applications and clinical progress.},
  author = {Keenan BP and Killebrew JR and Hollenbaugh D and Fong L},
  year = {2026},
  journal = {Nature reviews. Drug discovery},
  doi = {10.1038/s41573-026-01552-x},
  url = {https://doi.org/10.1038/s41573-026-01552-x}
}

RIS

TY  - JOUR
TI  - Conditional biologics in cancer immunotherapy: mechanisms, applications and clinical progress.
AU  - Keenan BP
AU  - Killebrew JR
AU  - Hollenbaugh D
AU  - Fong L
PY  - 2026
JO  - Nature reviews. Drug discovery
DO  - 10.1038/s41573-026-01552-x
UR  - https://doi.org/10.1038/s41573-026-01552-x
ER  -

APA

BP, K., JR, K., D, H., & L, F. (2026). Conditional biologics in cancer immunotherapy: mechanisms, applications and clinical progress.. Nature reviews. Drug discovery. https://doi.org/10.1038/s41573-026-01552-x

Source records

pubmed · retrieved 2026-11-10T16:52:43.603Z